About Us

The Growing Gene and Cell Therapy (GGACT) cooperative was established in 2016 to support investigators to rapidly translate complex gene and cell therapies to early phase, investigator-initiated clinical trials. The founding collaborative centers (Boston Children’s Hospital, Cincinnati Children’s Hospital Medical Center, and the University of California Los Angeles) have a history of working together to implement pioneering gene and cell therapy pediatric trials, and their experiences have required the development of both expertise and significant infrastructure at each institution that focuses on preclinical models of disease and testing, process development, GMP vector production and cellular manufacturing, protocol development and implementation, trial and data management and regulatory expertise that is specifically focused on early phase biologics in a manner suitable for transferring to industry for later phase studies.

GGACT is supported by NCATS U01TR001814 (“Disseminating Curative Biological Therapies for Rare Pediatric Diseases”): funding which will conclude on June 30, 2021.  All currently supported projects will continue to receive support until this date, and our application cycle is now closed indefinitely.